127 related articles for article (PubMed ID: 15276239)
1. Application of a novel Active Allothetic Place Avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: comparison with the Morris Water Maze.
Stuchlik A; Rezacova L; Vales K; Bubenikova V; Kubik S
Neurosci Lett; 2004 Aug; 366(2):162-6. PubMed ID: 15276239
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
Stuchlík A; Vales K
Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
[TBL] [Abstract][Full Text] [Related]
3. Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats.
Vales K; Bubenikova-Valesova V; Klement D; Stuchlik A
Neurosci Res; 2006 Aug; 55(4):383-8. PubMed ID: 16712995
[TBL] [Abstract][Full Text] [Related]
4. Central muscarinic blockade interferes with retrieval and reacquisition of active allothetic place avoidance despite spatial pretraining.
Vales K; Stuchlik A
Behav Brain Res; 2005 Jun; 161(2):238-44. PubMed ID: 15922050
[TBL] [Abstract][Full Text] [Related]
5. The effect of dizocilpine (MK-801) on conditional discrimination learning in the rat.
Murray TK; Ridley RM
Behav Pharmacol; 1997 Oct; 8(5):383-8. PubMed ID: 9832977
[TBL] [Abstract][Full Text] [Related]
6. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.
Pitkänen M; Sirviö J; MacDonald E; Niemi S; Ekonsalo T; Riekkinen P
Eur Neuropsychopharmacol; 1995 Dec; 5(4):457-63. PubMed ID: 8998397
[TBL] [Abstract][Full Text] [Related]
7. Posttraining injections of MK-801 produce a time-dependent impairment of memory in two water maze tasks.
Packard MG; Teather LA
Neurobiol Learn Mem; 1997 Jul; 68(1):42-50. PubMed ID: 9195588
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats.
O'Donnell J; Stemmelin J; Nitta A; Brouillette J; Quirion R
Synapse; 2003 Dec; 50(3):171-80. PubMed ID: 14515334
[TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine D1 receptor antagonist SCH23390 and D1 agonist A77636 on active allothetic place avoidance, a spatial cognition task.
Stuchlik A; Vales K
Behav Brain Res; 2006 Sep; 172(2):250-5. PubMed ID: 16781786
[TBL] [Abstract][Full Text] [Related]
10. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
11. Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning.
Kawabe K; Iwasaki T; Ichitani Y
Brain Res; 2007 Sep; 1169():77-86. PubMed ID: 17706184
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptors in the medial septal area have a role in spatial and emotional learning in the rat.
Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO
Neuroscience; 2006 Nov; 142(4):963-78. PubMed ID: 16952425
[TBL] [Abstract][Full Text] [Related]
13. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
[TBL] [Abstract][Full Text] [Related]
14. NMDA antagonist MK-801 does not interfere with the use of spatial representation in a familiar environment.
Uekita T; Okaichi H
Behav Neurosci; 2005 Apr; 119(2):548-56. PubMed ID: 15839801
[TBL] [Abstract][Full Text] [Related]
15. Acute ethanol administration and acute allopregnanolone administration impair spatial memory in the Morris water task.
Matthews DB; Morrow AL; Tokunaga S; McDaniel JR
Alcohol Clin Exp Res; 2002 Nov; 26(11):1747-51. PubMed ID: 12436065
[TBL] [Abstract][Full Text] [Related]
16. NMDA antagonist MK-801 impairs acquisition of place strategies, but not their use.
Mackes JL; Willner J
Behav Brain Res; 2006 Nov; 175(1):112-8. PubMed ID: 16970996
[TBL] [Abstract][Full Text] [Related]
17. Further study of the effects of dopaminergic D1 drugs on place avoidance behavior using pretraining: some negative evidence.
Stuchlik A
Behav Brain Res; 2007 Mar; 178(1):47-52. PubMed ID: 17207865
[TBL] [Abstract][Full Text] [Related]
18. Evidence for disrupted NMDA receptor function in tissue plasminogen activator knockout mice.
Horwood JM; Ripley TL; Stephens DN
Behav Brain Res; 2004 Apr; 150(1-2):127-38. PubMed ID: 15033286
[TBL] [Abstract][Full Text] [Related]
19. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
[TBL] [Abstract][Full Text] [Related]
20. A behavioral analysis of the spatial learning deficit induced by the NMDA receptor antagonist MK-801 (dizocilpine) in the rat.
Ahlander M; Misane I; Schött PA; Ogren SO
Neuropsychopharmacology; 1999 Sep; 21(3):414-26. PubMed ID: 10457539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
